questionsmedicales.fr
Facteurs biologiques
Marqueurs biologiques
Antigènes de différenciation
Antigènes de différenciation : Questions médicales fréquentes
Diagnostic
5
Antigènes de différenciation
Biopsie
Diagnostic
Immunohistochimie
Cytométrie en flux
Antigènes de différenciation
Cancer
Maladies auto-immunes
Antigènes de différenciation
Suivi
Traitement
Antigènes de différenciation
Lymphocytes
Cellules tumorales
Antigènes de différenciation
Symptômes
5
Symptômes
Antigènes de différenciation
Maladies
Antigènes de différenciation
Cellules anormales
Symptômes
Antigènes de différenciation
Maladies
Symptômes
Prédiction
Antigènes de différenciation
Évolution
Antigènes de différenciation
Cancer
Symptômes
Prévention
5
Prévention
Dépistage
Antigènes de différenciation
Vaccination
Antigènes de différenciation
Cancer
Facteurs de risque
Antigènes de différenciation
Agents cancérigènes
Alimentation
Prévention
Antigènes de différenciation
Dépistage
Antigènes de différenciation
Prévention
Traitements
5
Immunothérapie
Antigènes de différenciation
Traitements
Thérapies ciblées
Antigènes de différenciation
Traitement
Thérapie génique
Antigènes de différenciation
Cancer
Vaccins
Antigènes de différenciation
Cancer
Antigènes de différenciation
Traitements
Tumeur
Complications
5
Complications
Antigènes de différenciation
Réponses immunitaires
Maladies auto-immunes
Antigènes de différenciation
Inflammation
Pronostic
Antigènes de différenciation
Tumeur
Antigènes de différenciation
Complications
Types
Gestion
Antigènes de différenciation
Complications
Facteurs de risque
5
Facteurs de risque
Antigènes de différenciation
Agents cancérigènes
Hérédité
Antigènes de différenciation
Mutations
Mode de vie
Antigènes de différenciation
Tabagisme
Infections
Antigènes de différenciation
Virales
Stress
Antigènes de différenciation
Système immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Antigènes de différenciation : Questions médicales les plus fréquentes",
"headline": "Antigènes de différenciation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Antigènes de différenciation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-21",
"dateModified": "2026-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Antigènes de différenciation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Marqueurs biologiques",
"url": "https://questionsmedicales.fr/mesh/D015415",
"about": {
"@type": "MedicalCondition",
"name": "Marqueurs biologiques",
"code": {
"@type": "MedicalCode",
"code": "D015415",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD",
"alternateName": "Antigens, CD",
"url": "https://questionsmedicales.fr/mesh/D015703",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD",
"code": {
"@type": "MedicalCode",
"code": "D015703",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.110"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD34",
"alternateName": "Antigens, CD34",
"url": "https://questionsmedicales.fr/mesh/D018952",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD34",
"code": {
"@type": "MedicalCode",
"code": "D018952",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.110.134"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigènes de différenciation des lymphocytes B",
"alternateName": "Antigens, Differentiation, B-Lymphocyte",
"url": "https://questionsmedicales.fr/mesh/D000944",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes de différenciation des lymphocytes B",
"code": {
"@type": "MedicalCode",
"code": "D000944",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.150"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD19",
"alternateName": "Antigens, CD19",
"url": "https://questionsmedicales.fr/mesh/D018941",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD19",
"code": {
"@type": "MedicalCode",
"code": "D018941",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.150.119"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD20",
"alternateName": "Antigens, CD20",
"url": "https://questionsmedicales.fr/mesh/D018951",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD20",
"code": {
"@type": "MedicalCode",
"code": "D018951",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.150.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD40",
"alternateName": "CD40 Antigens",
"url": "https://questionsmedicales.fr/mesh/D019013",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD40",
"code": {
"@type": "MedicalCode",
"code": "D019013",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.150.140"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigènes de différenciation des lymphocytes T",
"alternateName": "Antigens, Differentiation, T-Lymphocyte",
"url": "https://questionsmedicales.fr/mesh/D000945",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes de différenciation des lymphocytes T",
"code": {
"@type": "MedicalCode",
"code": "D000945",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD1",
"alternateName": "Antigens, CD1",
"url": "https://questionsmedicales.fr/mesh/D018949",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD1",
"code": {
"@type": "MedicalCode",
"code": "D018949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.080"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigène CD1d",
"alternateName": "Antigens, CD1d",
"url": "https://questionsmedicales.fr/mesh/D055610",
"about": {
"@type": "MedicalCondition",
"name": "Antigène CD1d",
"code": {
"@type": "MedicalCode",
"code": "D055610",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.080.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigène CD1d",
"alternateName": "Antigens, CD1d",
"url": "https://questionsmedicales.fr/mesh/D055610",
"about": {
"@type": "MedicalCondition",
"name": "Antigène CD1d",
"code": {
"@type": "MedicalCode",
"code": "D055610",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.080.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD2",
"alternateName": "CD2 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018801",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD2",
"code": {
"@type": "MedicalCode",
"code": "D018801",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.090"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD3",
"alternateName": "CD3 Complex",
"url": "https://questionsmedicales.fr/mesh/D017252",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD3",
"code": {
"@type": "MedicalCode",
"code": "D017252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.095"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Complexe CD3-récepteur à antigène des lymphocytes T",
"alternateName": "Receptor-CD3 Complex, Antigen, T-Cell",
"url": "https://questionsmedicales.fr/mesh/D017260",
"about": {
"@type": "MedicalCondition",
"name": "Complexe CD3-récepteur à antigène des lymphocytes T",
"code": {
"@type": "MedicalCode",
"code": "D017260",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.095.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Complexe CD3-récepteur à antigène des lymphocytes T",
"alternateName": "Receptor-CD3 Complex, Antigen, T-Cell",
"url": "https://questionsmedicales.fr/mesh/D017260",
"about": {
"@type": "MedicalCondition",
"name": "Complexe CD3-récepteur à antigène des lymphocytes T",
"code": {
"@type": "MedicalCode",
"code": "D017260",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.095.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD4",
"alternateName": "CD4 Antigens",
"url": "https://questionsmedicales.fr/mesh/D015704",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD4",
"code": {
"@type": "MedicalCode",
"code": "D015704",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD5",
"alternateName": "CD5 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018956",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD5",
"code": {
"@type": "MedicalCode",
"code": "D018956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.101"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD7",
"alternateName": "Antigens, CD7",
"url": "https://questionsmedicales.fr/mesh/D019011",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD7",
"code": {
"@type": "MedicalCode",
"code": "D019011",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.107"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD8",
"alternateName": "CD8 Antigens",
"url": "https://questionsmedicales.fr/mesh/D016827",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD8",
"code": {
"@type": "MedicalCode",
"code": "D016827",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.108"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD13",
"alternateName": "CD13 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018826",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD13",
"code": {
"@type": "MedicalCode",
"code": "D018826",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.113"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD18",
"alternateName": "CD18 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018821",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD18",
"code": {
"@type": "MedicalCode",
"code": "D018821",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.118"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine LAG-3",
"alternateName": "Lymphocyte Activation Gene 3 Protein",
"url": "https://questionsmedicales.fr/mesh/D000093322",
"about": {
"@type": "MedicalCondition",
"name": "Protéine LAG-3",
"code": {
"@type": "MedicalCode",
"code": "D000093322",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.121"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes Thy-1",
"alternateName": "Thy-1 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018800",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes Thy-1",
"code": {
"@type": "MedicalCode",
"code": "D018800",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.123"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD27",
"alternateName": "Tumor Necrosis Factor Receptor Superfamily, Member 7",
"url": "https://questionsmedicales.fr/mesh/D018127",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD27",
"code": {
"@type": "MedicalCode",
"code": "D018127",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.127"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène CD28",
"alternateName": "CD28 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018106",
"about": {
"@type": "MedicalCondition",
"name": "Antigène CD28",
"code": {
"@type": "MedicalCode",
"code": "D018106",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.128"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD56",
"alternateName": "CD56 Antigen",
"url": "https://questionsmedicales.fr/mesh/D019002",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD56",
"code": {
"@type": "MedicalCode",
"code": "D019002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.156"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD57",
"alternateName": "CD57 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018959",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD57",
"code": {
"@type": "MedicalCode",
"code": "D018959",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.157"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène CTLA-4",
"alternateName": "CTLA-4 Antigen",
"url": "https://questionsmedicales.fr/mesh/D060908",
"about": {
"@type": "MedicalCondition",
"name": "Antigène CTLA-4",
"code": {
"@type": "MedicalCode",
"code": "D060908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.158"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dipeptidyl peptidase 4",
"alternateName": "Dipeptidyl Peptidase 4",
"url": "https://questionsmedicales.fr/mesh/D018819",
"about": {
"@type": "MedicalCondition",
"name": "Dipeptidyl peptidase 4",
"code": {
"@type": "MedicalCode",
"code": "D018819",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.160"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine inductible de costimulation du lymphocyte T",
"alternateName": "Inducible T-Cell Co-Stimulator Protein",
"url": "https://questionsmedicales.fr/mesh/D060889",
"about": {
"@type": "MedicalCondition",
"name": "Protéine inductible de costimulation du lymphocyte T",
"code": {
"@type": "MedicalCode",
"code": "D060889",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.580"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur-1 de mort cellulaire programmée",
"alternateName": "Programmed Cell Death 1 Receptor",
"url": "https://questionsmedicales.fr/mesh/D061026",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur-1 de mort cellulaire programmée",
"code": {
"@type": "MedicalCode",
"code": "D061026",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.894.790"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigènes de différenciation des myélomonocytes",
"alternateName": "Antigens, Differentiation, Myelomonocytic",
"url": "https://questionsmedicales.fr/mesh/D015214",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes de différenciation des myélomonocytes",
"code": {
"@type": "MedicalCode",
"code": "D015214",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.900"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD14",
"alternateName": "Lipopolysaccharide Receptors",
"url": "https://questionsmedicales.fr/mesh/D018950",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD14",
"code": {
"@type": "MedicalCode",
"code": "D018950",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.900.045"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD31",
"alternateName": "Platelet Endothelial Cell Adhesion Molecule-1",
"url": "https://questionsmedicales.fr/mesh/D019408",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD31",
"code": {
"@type": "MedicalCode",
"code": "D019408",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.900.131"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lectine-3 de type Ig liant l'acide sialique",
"alternateName": "Sialic Acid Binding Ig-like Lectin 3",
"url": "https://questionsmedicales.fr/mesh/D063268",
"about": {
"@type": "MedicalCondition",
"name": "Lectine-3 de type Ig liant l'acide sialique",
"code": {
"@type": "MedicalCode",
"code": "D063268",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.900.565"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigènes Ly",
"alternateName": "Antigens, Ly",
"url": "https://questionsmedicales.fr/mesh/D000950",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes Ly",
"code": {
"@type": "MedicalCode",
"code": "D000950",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.920"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sous-famille A des récepteurs de cellules NK de type lectine",
"alternateName": "NK Cell Lectin-Like Receptor Subfamily A",
"url": "https://questionsmedicales.fr/mesh/D055650",
"about": {
"@type": "MedicalCondition",
"name": "Sous-famille A des récepteurs de cellules NK de type lectine",
"code": {
"@type": "MedicalCode",
"code": "D055650",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.920.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigène CD52",
"alternateName": "CD52 Antigen",
"url": "https://questionsmedicales.fr/mesh/D000074301",
"about": {
"@type": "MedicalCondition",
"name": "Antigène CD52",
"code": {
"@type": "MedicalCode",
"code": "D000074301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.943"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes embryonnaires spécifiques de stade",
"alternateName": "Stage-Specific Embryonic Antigens",
"url": "https://questionsmedicales.fr/mesh/D055746",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes embryonnaires spécifiques de stade",
"code": {
"@type": "MedicalCode",
"code": "D055746",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.101.100.965"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Antigènes de différenciation",
"alternateName": "Antigens, Differentiation",
"code": {
"@type": "MedicalCode",
"code": "D000943",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Eliza Mari Kwesi-Maliepaard",
"url": "https://questionsmedicales.fr/author/Eliza%20Mari%20Kwesi-Maliepaard",
"affiliation": {
"@type": "Organization",
"name": "Division of Gene Regulation, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands."
}
},
{
"@type": "Person",
"name": "Heinz Jacobs",
"url": "https://questionsmedicales.fr/author/Heinz%20Jacobs",
"affiliation": {
"@type": "Organization",
"name": "Division of Tumor Biology and Immunology, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands."
}
},
{
"@type": "Person",
"name": "Fred van Leeuwen",
"url": "https://questionsmedicales.fr/author/Fred%20van%20Leeuwen",
"affiliation": {
"@type": "Organization",
"name": "Division of Gene Regulation, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands. fred.v.leeuwen@nki.nl."
}
},
{
"@type": "Person",
"name": "S Marieke van Ham",
"url": "https://questionsmedicales.fr/author/S%20Marieke%20van%20Ham",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands."
}
},
{
"@type": "Person",
"name": "Anja Ten Brinke",
"url": "https://questionsmedicales.fr/author/Anja%20Ten%20Brinke",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: A.tenbrinke@sanquin.nl."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37240204",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24108861"
}
},
{
"@type": "ScholarlyArticle",
"name": "17β-estradiol mitigates the inhibition of SH-SY5Y cell differentiation through WNT1 expression.",
"datePublished": "2023-10-31",
"url": "https://questionsmedicales.fr/article/37914154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cdev.2023.203881"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunohistochemical study of the expressed cluster differentiation markers proteins type 20 and 56 in breast tissues from a group of Iraqi patients with breast cancers.",
"datePublished": "2023-10-01",
"url": "https://questionsmedicales.fr/article/37898871",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31557/APJCP.2023.24.10.3621"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pevonedistat Inhibits SOX2 Expression and Sphere Formation but Also Drives the Induction of Terminal Differentiation Markers and Apoptosis within Arsenite-Transformed Urothelial Cells.",
"datePublished": "2023-05-23",
"url": "https://questionsmedicales.fr/article/37298099",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24119149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antimelanoma differentiation antigen 5-positive dermatomyositis: an update.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39007238",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/BOR.0000000000001034"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Marqueurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D015415"
},
{
"@type": "ListItem",
"position": 4,
"name": "Antigènes de différenciation",
"item": "https://questionsmedicales.fr/mesh/D000943"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Antigènes de différenciation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Antigènes de différenciation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Antigènes de différenciation",
"description": "Comment les antigènes de différenciation sont-ils utilisés au diagnostic ?\nQuels tests détectent les antigènes de différenciation ?\nLes antigènes de différenciation sont-ils spécifiques à certaines maladies ?\nPeut-on utiliser les antigènes de différenciation pour le suivi des traitements ?\nQuels types de cellules expriment des antigènes de différenciation ?",
"url": "https://questionsmedicales.fr/mesh/D000943#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Antigènes de différenciation",
"description": "Les antigènes de différenciation causent-ils des symptômes ?\nComment les antigènes de différenciation sont-ils liés aux symptômes ?\nLes symptômes varient-ils selon les antigènes de différenciation ?\nPeut-on prédire des symptômes par les antigènes de différenciation ?\nLes antigènes de différenciation sont-ils liés à des symptômes spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D000943#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Antigènes de différenciation",
"description": "Peut-on prévenir les maladies liées aux antigènes de différenciation ?\nLes vaccinations aident-elles à prévenir les maladies liées aux antigènes ?\nQuels facteurs de risque influencent les antigènes de différenciation ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes dépistages réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D000943#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Antigènes de différenciation",
"description": "Les antigènes de différenciation sont-ils ciblés par des traitements ?\nComment les antigènes de différenciation influencent-ils le traitement ?\nLes antigènes de différenciation sont-ils utilisés en thérapie génique ?\nPeut-on développer des vaccins basés sur des antigènes de différenciation ?\nLes traitements varient-ils selon les antigènes de différenciation ?",
"url": "https://questionsmedicales.fr/mesh/D000943#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Antigènes de différenciation",
"description": "Quelles complications peuvent survenir avec des antigènes de différenciation ?\nLes antigènes de différenciation sont-ils liés à des complications auto-immunes ?\nComment les antigènes de différenciation affectent-ils le pronostic ?\nLes complications varient-elles selon le type d'antigène ?\nPeut-on gérer les complications liées aux antigènes de différenciation ?",
"url": "https://questionsmedicales.fr/mesh/D000943#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Antigènes de différenciation",
"description": "Quels sont les principaux facteurs de risque liés aux antigènes de différenciation ?\nL'hérédité influence-t-elle les antigènes de différenciation ?\nLe mode de vie impacte-t-il les antigènes de différenciation ?\nLes infections peuvent-elles affecter les antigènes de différenciation ?\nLe stress a-t-il un impact sur les antigènes de différenciation ?",
"url": "https://questionsmedicales.fr/mesh/D000943#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les antigènes de différenciation sont-ils utilisés au diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à identifier des types cellulaires spécifiques dans les biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests détectent les antigènes de différenciation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests immunohistochimiques et les analyses de cytométrie en flux sont courants."
}
},
{
"@type": "Question",
"name": "Les antigènes de différenciation sont-ils spécifiques à certaines maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être spécifiques à certains types de cancers ou maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser les antigènes de différenciation pour le suivi des traitements ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur expression peut indiquer la réponse au traitement dans certains cancers."
}
},
{
"@type": "Question",
"name": "Quels types de cellules expriment des antigènes de différenciation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les lymphocytes, les cellules tumorales et d'autres cellules immunitaires en expriment."
}
},
{
"@type": "Question",
"name": "Les antigènes de différenciation causent-ils des symptômes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne causent pas de symptômes, mais leur présence peut indiquer une maladie."
}
},
{
"@type": "Question",
"name": "Comment les antigènes de différenciation sont-ils liés aux symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent indiquer la présence de cellules anormales, associées à des symptômes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les antigènes de différenciation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de cellule et de la maladie associée."
}
},
{
"@type": "Question",
"name": "Peut-on prédire des symptômes par les antigènes de différenciation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent aider à prédire l'évolution de certaines maladies, mais pas toujours."
}
},
{
"@type": "Question",
"name": "Les antigènes de différenciation sont-ils liés à des symptômes spécifiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains antigènes sont associés à des symptômes spécifiques dans les cancers."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux antigènes de différenciation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par des dépistages précoces et des modes de vie sains."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir les maladies liées aux antigènes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque de cancers associés à des antigènes."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les antigènes de différenciation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'exposition à des agents cancérigènes peuvent influencer leur expression."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire le risque de maladies associées aux antigènes."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de détecter précocement des anomalies liées aux antigènes de différenciation."
}
},
{
"@type": "Question",
"name": "Les antigènes de différenciation sont-ils ciblés par des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements immunothérapeutiques ciblent des antigènes spécifiques."
}
},
{
"@type": "Question",
"name": "Comment les antigènes de différenciation influencent-ils le traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à choisir des thérapies ciblées adaptées au profil cellulaire du patient."
}
},
{
"@type": "Question",
"name": "Les antigènes de différenciation sont-ils utilisés en thérapie génique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être des cibles pour des approches de thérapie génique dans certains cancers."
}
},
{
"@type": "Question",
"name": "Peut-on développer des vaccins basés sur des antigènes de différenciation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vaccins thérapeutiques ciblant ces antigènes sont en développement pour certains cancers."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon les antigènes de différenciation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choix du traitement dépend souvent du type d'antigène exprimé par la tumeur."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des antigènes de différenciation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des réponses immunitaires inappropriées ou des cancers."
}
},
{
"@type": "Question",
"name": "Les antigènes de différenciation sont-ils liés à des complications auto-immunes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur expression peut être impliquée dans des maladies auto-immunes et inflammatoires."
}
},
{
"@type": "Question",
"name": "Comment les antigènes de différenciation affectent-ils le pronostic ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer le pronostic en indiquant la agressivité d'une tumeur."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type d'antigène ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type d'antigène peut être associé à des complications spécifiques."
}
},
{
"@type": "Question",
"name": "Peut-on gérer les complications liées aux antigènes de différenciation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une gestion appropriée des traitements peut réduire les complications associées."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque liés aux antigènes de différenciation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'exposition à des agents cancérigènes et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'hérédité influence-t-elle les antigènes de différenciation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations génétiques héréditaires peuvent affecter l'expression des antigènes."
}
},
{
"@type": "Question",
"name": "Le mode de vie impacte-t-il les antigènes de différenciation ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme ou l'alimentation peuvent influencer leur expression."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles affecter les antigènes de différenciation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent induire l'expression d'antigènes de différenciation."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les antigènes de différenciation ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut influencer le système immunitaire et l'expression des antigènes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/04/2026
Contenu vérifié selon les dernières recommandations médicales
└─
Antigènes CD
Antigens, CD
D015703 -
D23.101.100.110
└─
Antigènes de différenciation des lymphocytes B
Antigens, Differentiation, B-Lymphocyte
D000944 -
D23.101.100.150
└─
Antigènes de différenciation des lymphocytes T
Antigens, Differentiation, T-Lymphocyte
D000945 -
D23.101.100.894
└─
Antigènes de différenciation des myélomonocytes
Antigens, Differentiation, Myelomonocytic
D015214 -
D23.101.100.900
└─
Antigènes Ly
Antigens, Ly
D000950 -
D23.101.100.920
└─
Antigène CD52
CD52 Antigen
D000074301 -
D23.101.100.943
└─
Antigènes embryonnaires spécifiques de stade
Stage-Specific Embryonic Antigens
D055746 -
D23.101.100.965
└─└─
Antigènes CD34
Antigens, CD34
D018952 -
D23.101.100.110.134
└─└─
Antigènes CD19
Antigens, CD19
D018941 -
D23.101.100.150.119
└─└─
Antigènes CD20
Antigens, CD20
D018951 -
D23.101.100.150.120
└─└─
Antigènes CD40
CD40 Antigens
D019013 -
D23.101.100.150.140
└─└─
Antigènes CD1
Antigens, CD1
D018949 -
D23.101.100.894.080
└─└─
Antigènes CD2
CD2 Antigens
D018801 -
D23.101.100.894.090
└─└─
Antigènes CD3
CD3 Complex
D017252 -
D23.101.100.894.095
└─└─
Antigènes CD4
CD4 Antigens
D015704 -
D23.101.100.894.100
└─└─
Antigènes CD5
CD5 Antigens
D018956 -
D23.101.100.894.101
└─└─
Antigènes CD7
Antigens, CD7
D019011 -
D23.101.100.894.107
└─└─
Antigènes CD8
CD8 Antigens
D016827 -
D23.101.100.894.108
└─└─
Antigènes CD13
CD13 Antigens
D018826 -
D23.101.100.894.113
└─└─
Antigènes CD18
CD18 Antigens
D018821 -
D23.101.100.894.118
└─└─
Protéine LAG-3
Lymphocyte Activation Gene 3 Protein
D000093322 -
D23.101.100.894.121
└─└─
Antigènes Thy-1
Thy-1 Antigens
D018800 -
D23.101.100.894.123
└─└─
Antigènes CD27
Tumor Necrosis Factor Receptor Superfamily, Member 7
D018127 -
D23.101.100.894.127
└─└─
Antigène CD28
CD28 Antigens
D018106 -
D23.101.100.894.128
└─└─
Antigènes CD56
CD56 Antigen
D019002 -
D23.101.100.894.156
└─└─
Antigènes CD57
CD57 Antigens
D018959 -
D23.101.100.894.157
└─└─
Antigène CTLA-4
CTLA-4 Antigen
D060908 -
D23.101.100.894.158
└─└─
Dipeptidyl peptidase 4
Dipeptidyl Peptidase 4
D018819 -
D23.101.100.894.160
└─└─
Protéine inductible de costimulation du lymphocyte T
Inducible T-Cell Co-Stimulator Protein
D060889 -
D23.101.100.894.580
└─└─
Récepteur-1 de mort cellulaire programmée
Programmed Cell Death 1 Receptor
D061026 -
D23.101.100.894.790
└─└─
Antigènes CD14
Lipopolysaccharide Receptors
D018950 -
D23.101.100.900.045
└─└─
Antigènes CD31
Platelet Endothelial Cell Adhesion Molecule-1
D019408 -
D23.101.100.900.131
└─└─
Lectine-3 de type Ig liant l'acide sialique
Sialic Acid Binding Ig-like Lectin 3
D063268 -
D23.101.100.900.565
└─└─
Sous-famille A des récepteurs de cellules NK de type lectine
NK Cell Lectin-Like Receptor Subfamily A
D055650 -
D23.101.100.920.500
└─└─└─
Antigène CD1d
Antigens, CD1d
D055610 -
D23.101.100.894.080.500
└─└─└─
Complexe CD3-récepteur à antigène des lymphocytes T
Receptor-CD3 Complex, Antigen, T-Cell
D017260 -
D23.101.100.894.095.800
2 publications dans cette catégorie
Affiliations :
Division of Gene Regulation, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Division of Tumor Biology and Immunology, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Division of Gene Regulation, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands. fred.v.leeuwen@nki.nl.
Department of Medical Biology, Amsterdam UMC, University of Amsterdam, 1105AZ, Amsterdam, The Netherlands. fred.v.leeuwen@nki.nl.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: A.tenbrinke@sanquin.nl.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Chembio Diagnostic Systems, Inc., Medford, NY 11763, USA.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Chembio Diagnostic Systems, Inc., Medford, NY 11763, USA.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Chembio Diagnostic Systems, Inc., Medford, NY 11763, USA.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Chembio Diagnostic Systems, Inc., Medford, NY 11763, USA.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Department of Science and Innovation-National Research Foundation Centre of Excellence for Biomedical TB Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Department of Science and Innovation-National Research Foundation Centre of Excellence for Biomedical TB Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, USA.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Chembio Diagnostic Systems, Inc., Medford, NY 11763, USA. Electronic address: klyashchenko@chembio.com.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Harvard Glycomics Center, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Harvard Glycomics Center, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Antigènes de différenciation" :
2 publications dans cette catégorie
Affiliations :
Department of Wound Repair and Dermatologic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei. lihaihong1051@126.com.
Publications dans "Antigènes de différenciation" :
1 publication dans cette catégorie
Affiliations :
Institute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn, Sigmund-Freud-Straße 25, 53105, Bonn, Germany. Tomabu.Adjobimey@ukb.uni-bonn.de.
Unité de Biochimie et de Biologie Moléculaire, Faculté des Sciences et Techniques (FAST), Université d'Abomey-Calavi, Abomey-Calavi, Bénin. Tomabu.Adjobimey@ukb.uni-bonn.de.
Publications dans "Antigènes de différenciation" :
1 publication dans cette catégorie
Affiliations :
Institute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn, Sigmund-Freud-Straße 25, 53105, Bonn, Germany.
Publications dans "Antigènes de différenciation" :
Microphthalmia-associated transcription factor (MITF) is an important regulator of melanogenesis and melanocyte development. In cutaneous melanoma, MITF loss has been linked to an increased expression...
17β-estradiol (E2) and canonical WNT-signaling represent crucial regulatory pathways for microtubule dynamics and synaptic formation. However, it is unclear yet whether E2-induced canonical WNT ligand...
Tumor-infiltrating lymphocytes (TIL) are important immunological components in response to cancers. Patients with higher numbers of TIL in breast cancerous tissues, comprising T- cytotoxic and T - hel...
To analyze the rate of the expressed surface biomarker proteins of CD20-B cells and CD56- NK cells on the infiltrative lymphocytic subpopulations in a group of breast tumorous tissues (invasive and be...
One hundred and 75 archived breast tissues were enrolled in this retrospective research: 100 archived breast from female patients with invasive breast cancers (BC) [20 well differentiated BC tissues; ...
The detection of IHC reactions for the expressed B cell CD20 - cell surface ( CD) biomarker proteins were observed in 53 out of 100 (53.0%) BC tissues, and in 24 out of 50 (48.0%) benign breast tumoro...
The observed significant rates that showed highly significant differences between both studied groups of breast malignant and benign tumor in comparison to the control group indicate that the CD20- po...
Urothelial cancer (UC) is a common malignancy and its development is associated with arsenic exposure. Around 25% of diagnosed UC cases are muscle invasive (MIUC) and are frequently associated with sq...
Antimelanoma differentiation antigen 5-dermatomyositis (MDA5-DM) is a complex and serious systemic autoimmune disease that primarily affects the skin and lungs. In this review, we aimed to provide new...
Although lung lesions are prominent in most patients with MDA5-DM, they are now recognized as heterogeneous diseases. Peripheral blood lymphocyte count can serve as a simple and reliable laboratory pa...
Knowledge of clinical characteristics and pathogenesis of MDA5-DM has grown in recent years. Although many new therapeutic approaches have been explored, further studies are required to confirm their ...
The Mycoplasma hyorhinis (Mhr) variable lipoprotein (Vlp) family, comprising Vlps A, B, C, D, E, F, and G, are highly variable in expression, size, and cytoadhesion capabilities across Mhr strains. Th...
Current immunologic methods cannot distinguish...
ATB patients (20), LTBI healthcare workers (25), fever patients (11), and healthy controls (10) were enrolled. Cytokine levels (IFN-γ, TNF-α, IL-2, IL-6, IP-10, IL-1Ra, CXCL-1, and MCP-1) were measure...
Without antigen stimulation, IL-6, IP-10, MCP-1, and IL-1Ra were higher in the ATB group than in the LTBI group (p<0.05), but no significant differences between the ATB group and the fever group. Stim...
Latency-associated antigens enhance multiple cytokine discriminatory ability, particularly TH1-type cytokines, for differentiating Mtb infection statuses....
ABO blood group antigens (ABH antigens) are carbohydrate chains glycosylated on epithelial and red blood cells. Recent findings suggest reduced ABH expression in psoriasis and atopic dermatitis, a chr...
Primary human keratinocytes were transfected with FUT1 siRNA or recombinant adenovirus for FUT1 overexpression. Cell adhesion and desmosome characteristics and their underlying mechanisms were analyze...
The knockdown of FUT1, responsible for H2 antigen expression in the skin, increased cell-cell adhesive strength and desmosome size in primary cultured keratinocytes without altering the overall desmos...
The expression level of FUT1 in the epidermis appears to influence cell-cell adhesion and keratinocyte differentiation status, at least partly through regulation of H2 antigen and EGFR ligand expressi...
We characterized the evolution and molecular characteristics of avian influenza A(H7N9) viruses isolated in China during 2021-2023. We systematically analyzed the 10-year evolution of the hemagglutini...
p53 can function as an independent and unfavorable prognosis biomarker in cancer patients. We tried to identify the key factors of the p53 signaling pathway involved in gastric cancer (GC) occurrence ...